Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE)

NCT01684878 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Gemcitabine (Chemotherapy)
DRUG: Paclitaxel (Chemotherapy)
DRUG: Pertuzumab
DRUG: Placebo
DRUG: Topotecan (Chemotherapy)

Sponsor

Hoffmann-La Roche